How is a pharmaceutical supply chain protected? Inside OLD PHARMA’s new Risk Assessment.
Recent geopolitical tensions in the Middle East, culminating in the involvement of Iran, are completely reshaping global logistics maps, forcing companies to act to safeguard and ensure business continuity.
For companies in the pharmaceutical sector, the stability of the supply chain for pharmaceutical raw materials is not just a matter of efficiency, but a fundamental requirement to ensure production continuity and public health.
In this scenario of high instability, OLD PHARMA responded promptly, transforming risk management into a tool for protection and transparency for the direct benefit of its Clients.
In this article, we will analyze the concrete measures adopted by OLD PHARMA to respond to the current geopolitical scenario, with the primary objective of protecting our customers’ business and ensuring the maximum regularity of supplies.
The impact of the geopolitical crisis on the pharmaceutical supply chain
The critical issues affecting the main international shipping routes can be grouped mainly into three risk factors:
- Increased costs due to the progressive rise in logistics rates and, above all, insurance rates for maritime transport.
- Forecasting and operational complexity caused by increased pressure on the availability of ships and containers, with the possible need to plan for and adopt alternative routes.
- Volatility of times and prices with an inevitable lengthening of transit times and potential fluctuation in the prices of the raw materials distributed.
OLD PHARMA’s Risk Assessment
To anticipate and manage these critical issues in order to protect supply flows, the OLD PHARMA team conducted an in-depth risk analysis, formalized in an official report.
This is not a simple theoretical analysis, but a concrete action plan based on the principles of Quality Risk Management, aimed at identifying and implementing specific preventive and corrective actions.
Our goal is to mitigate the effects of the geopolitical crisis to ensure that the customer has the goods promptly, reducing the risk of stock-outs to zero.
The reactive and proactive measures introduced in recent weeks by OLD PHARMA aim to stabilize supply and constantly monitor variations in transport and purchase costs, ensuring timely and transparent communication regarding any revisions to quotations.
OLD PHARMA’s advice for effective advance planning
OLD PHARMA has chosen to face this transition alongside each Client, evaluating customized solutions based on the specificity of the products and the volumes involved.
Today more than ever, advance planning represents the most effective tool for neutralizing the volatility of delivery times and securing business continuity.
To best face and manage the current macroeconomic context, OLD PHARMA therefore invites its partners to enhance joint planning through simple and targeted key actions.
It becomes fundamental to carefully re-verify the forecast regarding the estimated requirements for 2026, taking care to promptly share any updates on consumption forecasts with OLD PHARMA.
To neutralize the volatility of delivery times, it is strategic to plan the issuance of orders as far in advance as possible compared to normal production needs.
The implementation of these measures aims to ensure not only the maximum regularity of supplies and the stability of logistics flows, but also the operational peace of mind that our partners need to plan their production in a complex market.
In a time of high global instability, OLD PHARMA International thus confirms its role as a strategic ally, demonstrating that transparency, proactive risk management, and synergistic collaboration are the most effective tools for successfully overcoming any geopolitical and macroeconomic challenge.
